Bellicum Pharmaceuticals, Inc. Gains 19.5%
Thu, Feb 17, 2022 at 05:30 PM
Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) soared at $1.9, a gain of 19.5%. The stock appeared on our News Catalysts scanner on Wed, Jan 26, 2022 at 04:40 PM in the 'MISCELLANEOUS' category. From Tue, Feb 01, 2022, the stock recorded 40.00% Up Days and 18.18% Green Days
The stock spiked on Wed, Sep 01, 2021 at $4.04 with a volume of 13M+, and its share price has been moving sideways in recent weeks.
About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.
Top 10 Gainers:
- Inspirato Inc Cl A (ISPO:NASDAQ), 618.22%
- Cepton Inc Com (CPTN:NASDAQ), 343.51%
- Anghami Inc. (ANGH:NASDAQ), 161.36%
- Flotek Industries, Inc. (FTK:NYSE), 70.2%
- Quanergy Systems Inc. (QNGY:NYSE), 30.94%
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 21.18%
- International Tower Hill Mines Ltd. (THM:NYSEMKT), 19.54%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 19.5%
- IBEX Holdings Limited (IBEX:NASDAQ), 19.47%
- Grindrod Shipping Holdings Ltd. (GRIN:NASDAQ), 19.38%